Tech Company Financing Transactions

Neos Therapeutics Funding Round

Neos Therapeutics, operating out of Grand Prairie, secured $24.2 million from private investors.

Transaction Overview

Company Name
Announced On
12/7/2009
Transaction Type
Venture Equity
Amount
$24,200,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2940 N Hwy. 360 400
Grand Prairie, TX 75050
USA
Email Address
Overview
Neos Therapeutics (NASDAQ: NEOS) is a specialty pharmaceutical company that focuses on time-release technologies. We have developed a broad, cutting-edge portfolio of processes that allow for tailored and independent release profiles of single and multiple ingredients.
Profile
Neos Therapeutics LinkedIn Company Profile
Social Media
Neos Therapeutics Company Twitter Account
Company News
Neos Therapeutics News
Facebook
Neos Therapeutics on Facebook
YouTube
Neos Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jerry McLaughlin
  Jerry McLaughlin LinkedIn Profile  Jerry McLaughlin Twitter Account  Jerry McLaughlin News  Jerry McLaughlin on Facebook
Chief Financial Officer
Richard Eisenstadt
  Richard Eisenstadt LinkedIn Profile  Richard Eisenstadt Twitter Account  Richard Eisenstadt News  Richard Eisenstadt on Facebook
VP - General Counsel
John Limongelli
  John Limongelli LinkedIn Profile  John Limongelli Twitter Account  John Limongelli News  John Limongelli on Facebook
VP - Human Resources
Sarah Foster
  Sarah Foster LinkedIn Profile  Sarah Foster Twitter Account  Sarah Foster News  Sarah Foster on Facebook
VP - Operations
Margaret Cabano
  Margaret Cabano LinkedIn Profile  Margaret Cabano Twitter Account  Margaret Cabano News  Margaret Cabano on Facebook
VP - R & D
Russ McMahen
  Russ McMahen LinkedIn Profile  Russ McMahen Twitter Account  Russ McMahen News  Russ McMahen on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/7/2009: ElectronDB venture capital transaction
Next: 12/7/2009: Advanced Cell Technology venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary